or Try an Advanced Search...

    Technical Analysis for IVA - Inventiva S.A.

    Grade Last Price % Change Price Change
    D 2.92 -2.51% -0.08
    IVA closed down 2.51 percent on Monday, July 1, 2024, on 32 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical IVA trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    MACD Bullish Signal Line Cross Bullish -2.51%
    Calm After Storm Range Contraction -2.51%
    Narrow Range Bar Range Contraction -2.51%
    Inside Day Range Contraction -2.51%
    Wide Bands Range Expansion -2.51%
    Calm After Storm Range Contraction -1.19%
    Older End-of-Day Signals for IVA ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 2 % about 9 hours ago
    Gap Up Closed about 9 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    IVA Chart by TradingView
    Basic chart:

    Profile

    Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A

    Is IVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024
    Jun 21 Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
    Jun 18 Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA)
    May 30 Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
    May 30 Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024
    May 22 Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024
    May 21 Inventiva reports Q1 results
    May 21 Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
    May 17 Inventiva receives positive recommendation from DMC for late stage trial of NASH treatment
    May 16 Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
    See more IVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.75
    52 Week Low 2.52
    Average Volume 12,168
    200-Day Moving Average 3.79
    50-Day Moving Average 3.32
    20-Day Moving Average 3.10
    10-Day Moving Average 2.85
    Average True Range 0.22
    RSI (14) 42.53
    ADX 19.08
    +DI 22.22
    -DI 23.30
    Chandelier Exit (Long, 3 ATRs) 3.10
    Chandelier Exit (Short, 3 ATRs) 3.17
    Upper Bollinger Bands 3.75
    Lower Bollinger Band 2.45
    Percent B (%b) 0.36
    BandWidth 41.70
    MACD Line -0.15
    MACD Signal Line -0.16
    MACD Histogram 0.0083
    Fundamentals Value
    Market Cap 150.55 Million
    Num Shares 51.6 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -1.42
    Price-to-Sales 8.77
    Price-to-Book 2.64
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.24
    Resistance 3 (R3) 3.27 3.20 3.19
    Resistance 2 (R2) 3.20 3.11 3.18 3.17
    Resistance 1 (R1) 3.06 3.06 3.02 3.02 3.15
    Pivot Point 2.98 2.98 2.96 2.96 2.98
    Support 1 (S1) 2.84 2.90 2.80 2.81 2.68
    Support 2 (S2) 2.76 2.84 2.75 2.66
    Support 3 (S3) 2.62 2.76 2.64
    Support 4 (S4) 2.59